• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of T cells during stem cell-driven regeneration: towards design of efficient stem cell-based therapies

Research Project

Project/Area Number 15H06348
Research Category

Grant-in-Aid for Research Activity Start-up

Allocation TypeSingle-year Grants
Research Field Biomedical engineering/Biomaterial science and engineering
Research InstitutionOsaka University

Principal Investigator

MARTINO Mikael (Martino Mikael)  大阪大学, 免疫学フロンティア研究センター, 特任助教(常勤) (30741293)

Project Period (FY) 2015-08-28 – 2017-03-31
Project Status Declined (Fiscal Year 2016)
Budget Amount *help
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords再生医療 / 免疫学 / 幹細胞 / T細胞 / バイオマテリアル
Outline of Annual Research Achievements

As we are facing an aging population, regenerative medicine will play a key role in patient care. While the field is becoming one of the next major innovations in healthcare, clinical translations of therapies are often very modest. For this research project, I hypothesized that tissue regeneration is strongly regulated by a crosstalk between the adaptive immune system and tissue-resident stem cells. Specifically, subsets of T cells could act as either “antiregenerative” or as “proregenerative”, by regulating stem cell functions.
One the main goal for FY2015 was to determine which types of T cells and when are they recruited during stem cell-driven tissue healing. Using a bone regeneration model in the mouse, I found that T cells are recruited about 10 days following bone injury. The number of T cell is higher when the defects are treated with mesenchymal stem cells, especially the number of regulatory T cells.
The second goal was to determine whether T cells modulate stem cell-driven tissue healing. I found that mice with more regulatory T cells (regulatory T cells injected i.v.) significantly regenerate bone faster. In addition, when defect are treated with mesenchymal stem cells, mice with more regulatory T cells significantly regenerate bone faster.
The results of this research will serve as a base to design novel stem cell-based therapies.

Research Progress Status

翌年度、交付申請を辞退するため、記入しない。

Strategy for Future Research Activity

翌年度、交付申請を辞退するため、記入しない。

Report

(1 results)
  • 2015 Annual Research Report
  • Research Products

    (3 results)

All 2016 2015 Other

All Int'l Joint Research (1 results) Journal Article (1 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 1 results,  Open Access: 1 results) Patent(Industrial Property Rights) (1 results)

  • [Int'l Joint Research] スイス連邦工科大学チューリッヒ(スイス)

    • Related Report
      2015 Annual Research Report
  • [Journal Article] Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regeneration.2015

    • Author(s)
      Mikael M Martino, Kenta Maruyama, Scott Stanger, Takashi Satoh, Osamu Takeuchi, Ralph Muller, and Shizuo Akira
    • Journal Title

      Nature Communications

      Volume: 7 Issue: 1 Pages: 11051-11051

    • DOI

      10.1038/ncomms11051

    • NAID

      120005743659

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Patent(Industrial Property Rights)] 組織損傷治療剤2016

    • Inventor(s)
      丸山健太、ミカエル マルティーノ、審良静男
    • Industrial Property Rights Holder
      丸山健太、ミカエル マルティーノ、審良静男
    • Industrial Property Rights Type
      特許
    • Filing Date
      2016-03-16
    • Related Report
      2015 Annual Research Report

URL: 

Published: 2015-08-26   Modified: 2022-02-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi